For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Relay Therapeutics Inc’s stock clocked out at $6.73, up 1.36% from its previous closing price of $6.64. In other words, the price has increased by $1.36 from its previous closing price. On the day, 0.91 million shares were traded. RLAY stock price reached its highest trading level at $6.84 during the session, while it also had its lowest trading level at $6.56.
Ratios:
To gain a deeper understanding of RLAY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.64 and its Current Ratio is at 15.64. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when Rahmer Peter sold 245 shares for $7.51 per share. The transaction valued at 1,840 led to the insider holds 391,684 shares of the business.
Catinazzo Thomas sold 6,457 shares of RLAY for $48,184 on Sep 27 ’24. The Chief Financial Officer now owns 313,193 shares after completing the transaction at $7.46 per share. On Sep 27 ’24, another insider, Bergstrom Donald A, who serves as the President, R&D of the company, sold 648 shares for $7.51 each. As a result, the insider received 4,866 and left with 523,433 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1093362432 and an Enterprise Value of 263762464. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.05 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at 7.492 whereas that against EBITDA is -0.717.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -4.31%, while the 200-Day Moving Average is calculated to be -14.40%.
Shares Statistics:
It appears that RLAY traded 1.93M shares on average per day over the past three months and 1671970 shares per day over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 120.66M. Insiders hold about 25.73% of the company’s shares, while institutions hold 55.84% stake in the company. Shares short for RLAY as of 1727654400 were 12370375 with a Short Ratio of 6.42, compared to 1724976000 on 9065206. Therefore, it implies a Short% of Shares Outstanding of 12370375 and a Short% of Float of 9.3.
